Business Context and Reporting Period
This Form 8-K Current Report was filed by Intelligent Bio Solutions Inc. on November 5, 2023. The filing addresses corporate governance updates, specifically the retirement of a director and the scheduling of the 2023 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate events and does not contain financial performance data.
Material Changes
- Director Departure: David Jenkins informed the Board on November 6, 2023, of his decision to retire and not stand for reelection at the 2023 Annual Meeting. He serves as a member of the Compensation Committee and Chairperson of the Nominating Committee. His departure is not the result of any disagreement with the Company.
- Annual Meeting Date Change: The Board determined the 2023 Annual Meeting will be held virtually on or about December 13, 2023. This date is more than 30 days from the 2022 Annual Meeting, necessitating this filing to establish deadlines for shareholder proposals.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The primary procedural update is the establishment of a deadline for shareholder proposals and director nominations not intended for inclusion in the proxy statement. Such submissions must be received by the Company Secretary no later than November 16, 2023, at 5:00 P.M. Eastern Time.
Key Facts for Investor Verification
- David Jenkins will retire from the Board effective at the 2023 Annual Meeting.
- The 2023 Annual Meeting is scheduled for approximately December 13, 2023, to be held virtually.
- The record date for stockholders entitled to vote is October 20, 2023.
- The deadline for submitting shareholder proposals or director nominations outside of Rule 14a-8 is November 16, 2023.